Alexander I. Rolevich

7 ta ish

Respublika ixtisoslashtirilgan onkologiya va radiologiya ilmiy-amaliy tibbiyot markazi

1. Interobserver reproducibility of pathological variables in patients with high grade non-muscle invasive bladder cancer

   T.I. Nabebina, Alexander I. Rolevich, A. Ch. Dubrovsky +1

   MaqolaOAOchiq kirish20161 iqtibos

   ABIABI:AkademIndex/2016.article.001460

2. Role of the FGFR3 gene mutation status in predicting progression of non-muscle-invasive bladder cancer

   Alexander I. Rolevich, M. P. Smal, S. A. Krasnyi +1

   MaqolaOAOchiq kirish20150 iqtibos

   ABIABI:AkademIndex/2015.article.001211

3. Impact of a surgeon on the relapse-free survival of patients with non-muscle-invasive bladder cancer

   Alexander I. Rolevich

   MaqolaOAOchiq kirish20160 iqtibos

   ABIABI:AkademIndex/2016.article.001458

4. Effectiveness of transurethral resection under the control of photodynamic diagnosis and intravesical instillation of bacillus Calmette–Guérin in case of poorly differentiated non-muscle-invasive bladder cancer

   Alexander I. Rolevich

   MaqolaOAOchiq kirish20160 iqtibos

   ABIABI:AkademIndex/2016.article.001467

5. Assessment of recurrence and progression risk in patients with non-muscle invasive bladder cancer

   Alexander I. Rolevich, Л. В. Мириленко

   MaqolaOAOchiq kirish20160 iqtibos

   ABIABI:AkademIndex/2016.article.001469

6. INFLUENCE OF P16 GENE METHYLATION ON THE RISK OF PROGRESSION OF NON-MUSCLE INVASIVE BLADDER CANCER

   M. P. Smal, Nataliya V. Nikitchenko, Alexander I. Rolevich +3

   MaqolaOAOchiq kirish20180 iqtibos

   ABIABI:AkademIndex/2018.article.001832

7. ASSESSMENT OF A PROGNOSTIC VALUE OF CDKN2A AND TIMP3 GENE METHYLATION IN BLADDER CANCER

   M. P. Smal, Nataliya V. Nikitchenko, Alexander I. Rolevich +3

   MaqolaOAOchiq kirish20180 iqtibos

   ABIABI:AkademIndex/2018.article.001844